High correlation between the Roche COBAS ® AmpliPrep/COBAS ® TaqMan ® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes

Journal of Clinical Virology

Volumn 52, Issue 3, 2011, Pages 181-186

  Karasi, J C ^a,b   Dziezuk, F ^c   Quennery, L ^a   Forster S ^d   Reischl, U ^d   Colucci, G ^e   Schoener, D ^e   Seguin Devaux, C ^a   Schmit, J C ^a  

^a Retrovirology Laboratory Luxembourg   (Luxembourg)

^b Lab Natl de Ref   (Rwanda)

^c CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e Roche Diagnostics Ltd   (Switzerland)

Author keywords

HIV 1; Low level viremia; Real time PCR; Subtype; Viral load

Indexed keywords

VIRUS RNA;

ABBOTT ASSAY; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LUXEMBOURG; MAJOR CLINICAL STUDY; MOLECULAR PROBE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RWANDA; SEQUENCE ANALYSIS; TAQMAN TEST V2.0; VIREMIA; VIRUS CULTURE; VIRUS LOAD; VIRUS RECOMBINANT;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL LABORATORY TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 80054693272     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.07.002     Document Type: Article

References (35)

1. Katzenstein D.A., Hammer S.M., Hughes M.D., Gundacker H., Jackson J.B., Fiscus S., et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med 1996, 335:1091-1098.
2. O'Brien W.A., Hartigan P.M., Martin D., Esinhart J., Hill A., Benoit S., et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996, 334:426-431.
3. Mulder J., McKinney N., Christopherson C., Sninsky J., Greenfield L., Kwok S. Rapid simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994, 32:292-300.
4. Gatanaga H., Tsukada K., Honda H., Tanuma J., Yazaki H., Watanabe T., et al. Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Clin Infect Dis 2009, 48:260-262.
5. Lima V., Harrigan R., Montaner J.S. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J Acquir Immune Defic Syndr 2009, 51:3-6.
6. Smit E., Bhattacharya S., Osman H., Taylor S. Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay. J Acquir Immune Defic Syndr 2009, 51:364-365.
7. Damond F., Roquebert B., Benard A., Collin G., Miceli M., Yeni P., et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol 2007, 45:3436-3438.
8. Gueudin M., Plantier J.C., Lemee V., Schmitt M.P., Chartier L., Bourlet T., et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007, 44:500-505.
9. Grimwood National Antiretroviral Treatment Guidelines; 2004.
10. WHO. Rapid advice - antiretroviral therapy for HIV infection in adults and adolescents. World Health Organization 2009. 2009. http://www.who.int/hiv/pub/av/rapid-advice-art.
11. Huang S., Salituro J., Tang N., Luk K.C., Hackett J., Swanson P., et al. Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res 2007, 35:e101.
12. Luk K.C., Devare S.G., Hackett J.R. Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets. J Virol Methods 2007, 144:1-11.
13. Scott L., Carmona S., Stevens W. Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay. J Clin Microbiol 2009, 47:3400-3402.
14. Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J Clin Microbiol 2010, 48:1413-1416.
15. Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., et al. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol 2010, 49:41-46.
16. Taylor N., Schmid I., Egle A., Greil R., Patsch W., Oberkofler H. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals. Antivir Ther 2009, 14:1189-1193.
17. Crump J.A., Scott L.E., Msuya E., Morrissey A.B., Kimaro E.E., Shao J.F., et al. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. J Virol Methods 2009, 162:218-222.
18. Pas S., Rossen J.W., Schoener D., Thamke D., Pettersson A., Babiel R., et al. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2010, 48:1195-1200.
19. Scott L.E., Noble L.D., Moloi J., Erasmus L., Venter W.D., Stevens W. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J Clin Microbiol 2009, 47:2209-2217.
20. Sloma C.R., Germer J.J., Gerads T.M., Mandrekar J.N., Mitchell P.S., Yao J.D. Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs. J Clin Microbiol 2009, 47:889-895.
21. Swanson P., Holzmayer V., Huang S., Hay P., Adebiyi A., Rice P., et al. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. J Virol Methods 2006, 137:184-192.
22. Wirden M., Tubiana R., Fourati S., Thevenin M., Simon A., Canestri A., et al. Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations. J Clin Microbiol 2011.
23. Katsoulidou A., Rokka C., Issaris C., Haida C., Tzannis K., Sypsa V., et al. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virol J 2011, 8:10.
24. Paba P., Fabeni L., Ciccozzi M., Perno C.F., Ciotti M. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study. J Virol Methods 2011, 173:399-402.
25. Sire J.M., Vray M., Merzouk M., Plantier J.C., Pavie J., Maylin S., et al. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr 2011, 56:239-243.
26. Yan C.S., Hanafi I., Kelleher A.D., Carr A.D., Amin J., McNally L.P., et al. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. J Clin Virol 2010, 49:249-253.
27. Bourlet T., Signori-Schmuck A., Roche L., Icard V., Saoudin H., Trabaud M.A., et al. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol 2011, 49:292-297.
28. van Rensburg E.J., Tait K., Watt A., Schall R. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J Clin Microbiol 2011, 49:377-379.
29. Glaubitz J., Sizmann D., Simon C.O., Hoffmann K.S., Drogan D., Hesse M., et al. Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests. J Clin Virol 2011, 50:119-124.
30. Oliver A.R., Pereira S.F., Clark D.A. Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assay. J Clin Microbiol 2007, 45:3616-3619.
31. Verhofstede C., Van Wanzeele F., Reynaerts J., Mangelschots M., Plum J., Fransen K. Viral load assay sensitivity and low level viremia in HAART treated HIV patients. J Clin Virol 2010, 47:335-339.
32. Hatano H., Hunt P., Weidler J., Coakley E., Hoh R., Liegler T., et al. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clin Infect Dis 2006, 43:1329-1336.
33. Widdrington J., Payne B., Medhi M., Valappil M., Schmid M.L. The significance of very low-level viraemia detected by sensitive viral load assays in HIV infected patients on HAART. J Infect 2011, 62:87-92.
34. Rebeiro P.F., Kheshti A., Bebawy S.S., Stinnette S.E., Erdem H., Tang Y.W., et al. Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin Infect Dis 2008, 47:1354-1357.
35. Cohen C. Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen. HIV Clin Trials 2009, 10:116-124.